Q3 2023 · 13F-HR
72 Investment Holdings, LLCholdings as filed
Filed 2023-11-14 · accession 0000902664-23-005504
$14.9M
Reported value
5
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $8.0M | 53.9% | 509,023 | Common | SHARED |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $2.3M | 15.2% | 474,067 | Common | SHARED |
| 90042W100 | — | TURNSTONE BIOLOGICS CORP | $2.2M | 14.5% | 549,981 | Common | SHARED |
| 74006W108 | — | PRAXIS PRECISION MEDICINES I | $1.7M | 11.3% | 988,995 | Common | SHARED |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $758,823 | 5.08% | 352,941 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.